Support Team Posted October 25, 2011 Posted October 25, 2011 A new phase II trial for pancreatic cancer looking at sequential treatment with two cancer vaccines: Aduro's CRS-207 and GVAX Pancreas Cancer Vaccine (GVAX Pancreas)has begun recruting in the US.For more information see http://www.fiercebiotech.com/press-releases/aduro-biotech-announces-first-patient-treated-phase-2-pancreatic-cancer-tri-0?utm_medium=nl&utm_source=internalAnna
Recommended Posts